Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PROTEOSTASIS THERAPEUTICS, INC. | 78,650 | reported | 01 Apr 2021 | tx 7+912,943 |
| VERTEX PHARMACEUTICALS INC / MA | 68,840 | reported | 06 May 2004 | tx 3+81,320 |
| CRISPR Therapeutics AG | 15,000 | reported | 31 May 2017 | tx 4+100,000 |
| Campus Crest Communities, Inc. | 3,999 | reported | 22 Apr 2013 | tx 4+20,334−16,335 |
| LABCORP HOLDINGS INC. | 2,584 | reported | 15 Feb 2013 | tx 6+6,400−216 |
| REGENERON PHARMACEUTICALS, INC. | 1,962 | reported | 02 Jan 2026 | tx 71+75,300−63,423 |
| NPS PHARMACEUTICALS INC | 0 | reported | 17 Mar 2008 | tx 19+684,131−251,874 |
| ARYA Sciences Acquisition Corp II | 0 | reported | 01 Aug 2024 | tx 84+2,610,355−6,749,614 |
| ONYX PHARMACEUTICALS INC | 0 | reported | 01 Oct 2013 | tx 67+1,631,177−1,523,868 |
| MCKESSON CORP | 0 | reported | 17 Aug 2020 | tx 10+7,592−3,803 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 155 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,962 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 166 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 1,958 | 0.00 USD | deriv |
| 01 Aug 2024 | OTHER | ARYA Sciences Acquisition Corp II | 10,290 | — | |
| 01 Aug 2024 | OTHER | ARYA Sciences Acquisition Corp II | 15,638 | — | |
| 01 Aug 2024 | OTHER | ARYA Sciences Acquisition Corp II | 4,809,418 | — | deriv |
| 01 Aug 2024 | OTHER | ARYA Sciences Acquisition Corp II | 46,322 | 0.00 USD | deriv |
| 01 Jul 2024 | EXERCISE | ARYA Sciences Acquisition Corp II | 25,000 | 3.50 USD | |
| 01 Jul 2024 | SALE | ARYA Sciences Acquisition Corp II | 25,000 | 41.18 USD | |
| 01 Jul 2024 | EXERCISE | ARYA Sciences Acquisition Corp II | 25,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | ARYA Sciences Acquisition Corp II | 10,290 | — | |
| 03 Jun 2024 | SALE | ARYA Sciences Acquisition Corp II | 50,000 | 40.61 USD | |
| 03 Jun 2024 | EXERCISE | ARYA Sciences Acquisition Corp II | 50,000 | 3.50 USD | |
| 03 Jun 2024 | EXERCISE | ARYA Sciences Acquisition Corp II | 50,000 | 0.00 USD | deriv |
| 10 May 2024 | SALE | ARYA Sciences Acquisition Corp II | 50,000 | 42.10 USD | |
| 10 May 2024 | EXERCISE | ARYA Sciences Acquisition Corp II | 50,000 | 3.50 USD | |
| 10 May 2024 | EXERCISE | ARYA Sciences Acquisition Corp II | 50,000 | 0.00 USD | deriv |
| 01 Apr 2024 | SALE | ARYA Sciences Acquisition Corp II | 50,000 | 42.33 USD | |
| 01 Apr 2024 | EXERCISE | ARYA Sciences Acquisition Corp II | 50,000 | 3.50 USD | |
| 01 Apr 2024 | EXERCISE | ARYA Sciences Acquisition Corp II | 50,000 | 0.00 USD | deriv |
| 04 Mar 2024 | EXERCISE | ARYA Sciences Acquisition Corp II | 50,000 | 3.50 USD | |
| 04 Mar 2024 | SALE | ARYA Sciences Acquisition Corp II | 50,000 | 41.01 USD | |
| 04 Mar 2024 | EXERCISE | ARYA Sciences Acquisition Corp II | 50,000 | 0.00 USD | deriv |
| 29 Feb 2024 | EXERCISE | ARYA Sciences Acquisition Corp II | 50,000 | 3.50 USD |